Indigenous people in Australia experience three times more vision loss than non-Indigenous people, creating a concerning gap for vision. Much of this is due to diabetic...
The Research Brief is a short take about interesting academic work. The big idea When children get health insurance through Medicaid or the Children’s Health Insurance...
It seems every few weeks we hear about a new COVID variant, and it’s hard to know how concerned we ought to be. A “recombinant” variant...
With yet another COVID-19 booster available for vulnerable populations in the U.S., many people find themselves wondering what the end game will be. The mRNA vaccines...
Rashes can be thought of as a dysfunctional community of skin cells. Your skin harbors dozens of distinct cell types, including those that form blood vessels,...
Medicare finalized its decision to restrict its coverage of Aduhelm, Biogen’s new Alzheimer’s disease drug, on April 8, 2022. The decision means only patients who have...
In late March 2022, the U.S. Food and Drug Administration authorized a second booster shot of COVID-19 vaccines for vulnerable populations in the U.S., a move...
Cannabis has been used by humans for thousands of years and is one of the most popular drugs today. With effects such as feelings of joy...
We’ve all heard those people who say “running gives you a high” or “exercise is addictive,” but for many of us, it’s hard to love exercise....
OTTAWA — Health Canada has approved AstraZeneca’s antibody combination to prevent symptomatic COVID−19 infection in immunocompromised people. The drug, named Evusheld, is intended for people who...